1. Home
  2. TARS

TARS

Tarsus Pharmaceuticals Inc.

Logo Tarsus Pharmaceuticals Inc.

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-23-2024 12:30pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Founded: 2016 Country:
United States
United States
Employees: N/A City: IRVINE
Market Cap: 1.3B IPO Year: 2020
Target Price: $48.17 AVG Volume (30 days): 756.7K
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -4.62 EPS Growth: N/A
52 Week Low/High: $11.33 - $40.40 Next Earning Date: 05-07-2024
Revenue: $17,447,000 Revenue Growth: -32.42%
Revenue Growth (this year): 454.41% Revenue Growth (next year): 103.25%

Share on Social Networks: